All that may be true, in the meantime four years have passed. There is not an infinite amount of time to wait until they get it right, if they could possibly get through a clinical trial without any subterfuge. Their historical record shows otherwise. I have already posted my assessment.
The same outperforming drug Docetaxel was used in the Bavi + Doce arm.
You know the difference between a failing drug and a failing trial due to the outperforming of a decades old chemo drug, Docetaxel, that was used in the control arm with which we had to compare MOS.